http://www.nano.gov/timeline. Accessed on 23 June 2013.
http://www.britishmuseum.org/explore/highlights/highlight_objects/pe_mla/t/the_lycurgus_cup.aspx. Accessed on 23 June 2013.
http://www.nano.gov/nanotech-101/what/definition. Accessed on 23 June 2013.
Roco MC, Mirkin CA, Hersam MC. Nanotechnology Research Directions for Societal Needs in 2020, Retrospective and Outlook, Springer: Boston, 2010, pp. xxxvi–lviii. Available at: http://wtec.org/nano2/. Accessed on 23 June 2013.
Working Party on Nanotechnology, Organization for Economic Cooperation and Development. Background Paper 2: Finance and Investor Models in Nanotechnology, International Symposium on Assessing the Economic Impact of Nanotechnology, OECD/NNI, (16 March 2012).Google Scholar
Tullis TK. Current intellectual property issues in nanotechnology. Nanotechnol. Rev. 2012, 1, 189–205.Google Scholar
Dang Y, Zhang Y, Fan L, Chen H, Roco MC. Trends in worldwide nanotechnology patent applications: 1991 to 2008. J. Nanoparticle Res. 2010, 12, 687–706.Google Scholar
Bleeker RA, Troilo LM, Ciminello DP. Patenting nanotechnology. Mater. Today 2004, 7, 44–48.Google Scholar
Bawa R, Bawa SR, Maebius SB, Flynn T, Wei C. Protecting new ideas and inventions in nanomedicine with patents. Nanomed. Nanotechnol. Biol. Med. 2005, 1, 150–158.Google Scholar
http://www.nano.gov/nanotech-101/what. Accessed on 23 June 2013.
Scheu M, Veefkind V, Verbandt Y, Galan EM, Absalom R, Forstser W. World Patent Information 2006, 28, 204–211.Google Scholar
http://www.uspto.gov/web/patents/classification/uspc977/defs977.htm. Accessed on 23 June 2013.
Bastani B, Fernandez D. Intellectual property rights in nanotechnology. Thin Solid Films 2002, 420–421, 472–477.Google Scholar
35 USC § 101.Google Scholar
35 USC § 102.Google Scholar
35 USC § 103.Google Scholar
35 USC § 154, patent term may be 17 years from issue date, depending on the date of filing.Google Scholar
Uniform Trade Secrets Act.Google Scholar
http://www.bpmlegal.com/howforfile.html. Accessed on 21 April 2013.
Viksnins AS, McCrackin AM. A guide to international patent protection. In Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices, Chapter 10.6, MIHR: Oxford, UK and PIPRA: Davis, USA, 2007, pp. 927–939. Available at: http://www.ipHandbook.org. Accessed on 23 June 2013.
http://www.kaganbinder.com/docs/7-EstimatedPatentCosts.pdf. Accessed on 21 April 2013.
In re Bilski, 545 F.3d 943, 955-56 (Fed Cir. 2008) (en banc), Bilski v. Kappos, 130 S. Ct. 3218 (2010).Google Scholar
Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 US __,132 S.Ct. 1289, 101 USPQ2d 1961 (2012).Google Scholar
KSR Int’l Co. v. Teleflex, Inc., 550 US 398 (2007).Google Scholar
Graham v. John Deere Co., 383 US 1, 12.Google Scholar
In re Mouttet, 2011–1451 (26 June 2012).Google Scholar
Palfrey Q. The White House Blog (16 September 2011). Available at http://www.whitehouse.gov/blog/2011/09/16/america-invents-act-turning-ideas-jobs. Accessed on 23 June 2013.
AIA § 3(b), 35 USC § 102 (a),(b).Google Scholar
http://www.patentlyo.com/patent/2012/10/did-the-aia-eliminate-secret-prior-art.html. Accessed on 21 April 2013.
http://www.law360.com/articles/364102/new-first-to-file-rules-dispel-confusion-over-disclosures. Accessed on 27 July 2012.
Castro F. The America Invents Act and nanotechnology. Nanotechnol. Law Bus. 2011, 8, 214.Google Scholar
AIA § 3 (i).Google Scholar
AIA § 10 (b).Google Scholar
Agreement on Trade-Related Aspects of Intellectual Property Rights Article 27, 29, 33 ILM 1125, 1869 UNTS 299 (15 April 1994).Google Scholar
Barfield CE, Groombridge MA. Parallel trade in the pharmaceutical industry: implications for innovation, consumer welfare, and health policy. Fordham Intell. Prop. Media Ent. LJ 1999, 10, 185.Google Scholar
Bronckers MCEJ. The exhaustion of patent rights under WTO Law. J. World Trade 1998, 32, 137.Google Scholar
Lowensohn J. Jury awards Apple more than $1B, finds Samsung infringed. CNET. CBS Interactive. Accessed on 24 August 2012.Google Scholar
http://www.epo.org/law-practice/unitary/unitary-patent.html. Accessed on 22 March 2013.
http://www.nano.gov/you/standards. Accessed on 23 June 2013.
Harris D, Hermann K, Bawa R, Cleveland JT, O’Neill S. Strategies for resolving patent disputes over nanoparticle drug delivery systems. Nanotechnol. Law Bus. 2004, 1, 1–18.Google Scholar
Coffey DC, Ginger DS. Time-resolved electrostatic force microscopy of polymer solar cells. Nat. Mater. 2006, 5, 735–740.Google Scholar
Girit CO, Meyer JC, Erni R, Rossell MD, Kisielowski C, Yang L, Park CH, Crommie MF, Cohen ML, Louie SG, Zettl A. Graphene at the edge: stability and dynamics. Science 2009, 323, 1705–1708.Google Scholar
Bae S, Kim H, Lee Y, Xu X, Park JS, Zheng Y, Balakrishnan J, Lei T, Kim HR, Song YI, Kim YJ, Kim KS, Ozyilmaz B, Ahn JH, Hong BH, Iijima S. Roll-to-roll production of 30-inch graphene films for transparent electrodes. Nat. Nanotechnol. 2010, 5, 574–578.Google Scholar
Roco MC, Mirkin CA, Hersam MC. Nanotechnology Research Directions for Societal Needs in 2020, Retrospective and Outlook, Springer: Boston, 2010, p. 96. Available at: http://wtec.org/nano2/. Accessed on 23 June 2013.
Escoffier L. TTLF Working Papers, Standford-Vienna Transatlantic Technology Law Forum, No. 3, 2009.Google Scholar
Roco MC, Mirkin CA, Hersam MC, Nanotechnology Research Directions for Societal Needs in 2020, Retrospective and Outlook, Springer: Boston, 2010, p. 109. Available at: http://wtec.org/nano2/. Accessed on 23 June 2013.
Roco MC, Mirkin CA, Hersam MC, Nanotechnology Research Directions for Societal Needs in 2020, Retrospective and Outlook, Springer: Boston, 2010, p. 220. Available at: http://wtec.org/nano2/. Accessed on 23 June 2013.
Nam JM, Thaxton CS, Mirkin CA. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 2003, 301, 1884–1886.Google Scholar
Roco MC, Mirkin CA, Hersam MC. Nanotechnology Research Directions for Societal Needs in 2020, Retrospective and Outlook, Springer: Boston, 2010, pp. 227–247. Available at: http://wtec.org/nano2/. Accessed on 23 June 2013.
Sutton PJ, Pham CH, Toke J. Nanotechnology licence pitfalls. J. Intellectual Prop. Law Pract. 2009, 4, 176–180.Google Scholar
35 USC § 321; Public Law 112-29, Sec. 6(d), 125 Stat. 306 (16 September 2011).Google Scholar
35 USC § 318 (a), AIA § 6.Google Scholar
Prendergast WF, Schafer HN. Nanocrystalline pharmaceutical patent litigation: the first case. Nanotechnol. Law Bus. 2008, 5, 157.Google Scholar
US Patent No. 5,399,363 (issued 21 March 1995).Google Scholar
US Patent No. 5,834,025 (issued 10 November 1998).Google Scholar
Order (19 May 2008), Elan Pharma. Int’l, Ltd. v. Abraxis Biosci., Inc., No. 06-438 (D. Del. filed 19 July 2006).Google Scholar
Roco MC, Mirkin CA, Hersam MC. Nanotechnology Research Directions for Societal Needs in 2020, Retrospective and Outlook, Springer: Boston, 2010, p. 446. Available at: http://wtec.org/nano2/. Accessed on 23 June 2013.
35 USC § 111.Google Scholar
http://www.uspto.gov/web/offices/ac/qs/ope/fee031913.htm. Accessed on 23 March 2013.
35 USC § 112.Google Scholar
US Constitution, Article 1, § 8.Google Scholar
About the article
Dr. Yuanjia Zhang received her BS degree in materials science from Fudan University in Shanghai. She obtained her MS and PhD degrees in materials science and engineering in Cornell University in Ithaca, NY, USA, where she worked on nanoscale organic transistors in the group of Professor George Malliaras. In 2005, she joined R&D of Xerox Corporation in Webster, NY, where she spent 3 years in product development and 4 years in nanotechnology research. In 2012, she became a registered patent agent before the US Patent and Trademark Office and joined Fernandez & Associates. Her current interests are in all aspects of preparing and prosecuting patent applications.
Maisoun Sulfab is a registered patent agent at the US Patent Office with vast experience in analysis of biological data. Before obtaining her law degree from San Francisco Law School, Ms. Sulfab worked in discovery research and development for various drug discovery industries for the past 10 years. Ms. Sulfab received her MS degree in molecular and cellular biology from California State University at Sacramento, CA, USA, and her BS degree from Marymount University, Arlington, VA, USA.
Dennis Fernandez is a managing partner at Fernandez & Associates, LLP in Atherton, CA. He has over 30 years of experience in Silicon Valley and high-tech industry as a patent prosecutor and intellectual property litigator, venture capitalist, and engineering manager. He specializes in developing offensive and defensive patent strategies for start-up electronics, software, and biotechnology companies and their investors. Mr. Fernandez serves as strategic advisor to leading venture capital firms, including Sevin Rosen, Venrock, Charles River Ventures, and Walden International. Representative clients include Marvell Technology, SiRF Technology, Ayala Corporation, Stanford University, and Northwestern University as well as various start-up companies acquired by Cisco, Broadcom, Ciena, and Cadence Design Systems. He also serves on the editorial board of the Nanotechnology Law and Business Journal, the Board of Directors of the Association of Patent Law Firms, and the Science and Technology Advisory Council. Previously, Mr. Fernandez served on a consultancy with the United Nations Development Program on Asian economic development. Mr. Fernandez is also an inventor of several US and international patents in the areas of digital television, sensor networks, and bioinformatics. He has an electrical engineering degree from Northwestern University, a law degree from Suffolk University Law School, and is a registered US patent attorney.
Published Online: 2013-07-10
Published in Print: 2013-12-01